Publication

Article

BioPharm International

BioPharm International-10-02-2011
Volume2011 Supplement
Issue 7

BioPharm International, October 2011 Supplement

Advances in Vaccine Technologies

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Videos
How the 15% US-EU Tariff Cap Affects Bio/pharma
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dave Miller, PhD, Chief Scientific Officer, AustinPx
© 2025 MJH Life Sciences

All rights reserved.